Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1982 1
2001 1
2002 1
2003 4
2004 6
2005 8
2006 8
2007 3
2008 8
2009 10
2010 9
2011 4
2012 7
2013 6
2014 4
2015 8
2016 19
2017 14
2018 6
2019 8
2020 9
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, Gursky A, Siddiqui J, Tomlins SA, Roychowdhury S, Pienta KJ, Kim SY, Roberts JS, Rae JM, Van Poznak CH, Hayes DF, Chugh R, Kunju LP, Talpaz M, Schott AF, Chinnaiyan AM. Robinson DR, et al. Among authors: rae jm. Nat Genet. 2013 Dec;45(12):1446-51. doi: 10.1038/ng.2823. Epub 2013 Nov 3. Nat Genet. 2013. PMID: 24185510 Free PMC article.
Response.
Rae JM, Leyland-Jones B, Regan M. Rae JM, et al. J Natl Cancer Inst. 2014 Apr 3;106(5):dju064. doi: 10.1093/jnci/dju064. J Natl Cancer Inst. 2014. PMID: 24700799 No abstract available.
Pharmacogenetic Predictors of Response.
Hertz DL, Rae JM. Hertz DL, et al. Among authors: rae jm. Adv Exp Med Biol. 2016;882:191-215. doi: 10.1007/978-3-319-22909-6_8. Adv Exp Med Biol. 2016. PMID: 26987536 Review.
Pharmacogenomics and Endocrine Therapy in Breast Cancer.
Hayes DF, Rae JM. Hayes DF, et al. Among authors: rae jm. J Clin Oncol. 2020 Feb 20;38(6):525-528. doi: 10.1200/JCO.19.03119. Epub 2019 Dec 27. J Clin Oncol. 2020. PMID: 31880969 No abstract available.
Individualized Tamoxifen Dose Escalation-Response.
Hertz DL, Rae JM. Hertz DL, et al. Among authors: rae jm. Clin Cancer Res. 2016 Dec 15;22(24):6301. doi: 10.1158/1078-0432.CCR-16-2351. Clin Cancer Res. 2016. PMID: 27980025 Free PMC article. No abstract available.
133 results